Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • LabTwin’s AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API

    Jun 25, 2019, 10:37 AM by Michael Croft
    BERLIN, N/A, GERMANY - Jun 3, 2019 - LabTwin  GmbH, the world's first voice and AI-powered digital lab assistant, today announced its new open API that will connect scientists with data sources both inside and outside of the lab
    Full story
  • Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships

    Jun 25, 2019, 09:43 AM by Michael Croft
    PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
    Full story
  • Sentieon's 'Faster/Cheaper' Genomics Tools

    Jun 25, 2019, 08:50 AM by Michael Croft

    Bio-IT World | Sentieon's DNAseq and TNseq software, are making waves in the life sciences, creating a "drop in replacement" that is a faster and cheaper alternative to the industry standard for secondary analysis in next-generation sequencing (NGS) data processing while producing the industry standard results.

    Full story
  • Medherant positions itself for the next stage of its development with the appointment of a new CEO

    Jun 25, 2019, 06:13 AM by Michael Croft
    COVENTRY, UK - Jun 25, 2019 - Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019
    Full story
  • Creative Proteomics Has Launched a Wide Range of Newly-developed Proteomics Analysis Services for Biologists

    Jun 25, 2019, 03:12 AM by Michael Croft
    SHIRLEY, NY, US - Jun 25, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently released its several newly-developed proteomics services to researchers
    Full story
  • Positive Technologies launches PT Application Inspector Enterprise to create secure web applications

    Jun 24, 2019, 19:58 PM by Michael Croft
    FRANGINGHAM, MA, UNITED STATES - Jun 24, 2019 - Positive Technologies today unveiled PT Application Inspector Enterprise (PT AI Enterprise), a solution that automatically detects vulnerabilities and offers security experts the verification tools they need to secure web applications
    Full story
  • Tracking The Clinical And Preclinical Progress In Targeting Membrane Proteins

    Jun 24, 2019, 11:45 AM by Michael Croft

    Bio-IT World | G protein-coupled receptors (GPCRs), ion channels, and transporters represent some of the most important drug target classes across a wide range of diseases. According to Catherine Hutchings, progress in targeting these membrane proteins requires a recognition of not only what works, but also what doesn't.

    Full story
  • Officials Say They Lack Authority To Halt CRISPR Babies Plan In Russia

    Jun 24, 2019, 11:35 AM by Michael Croft

    STAT | Two influential leaders in science for the first time publicly condemned a Russian biologist who said he plans to produce gene-edited babies but conceded that it was beyond their organizations’ authority to halt him from doing so.

    Full story
  • CD Genomics Announces Highly Sensitive and Accurate Genome Sequencing Services Related to Genome Research

    Jun 24, 2019, 05:59 AM by Michael Croft
    SHIRLEY, NY - Jun 24, 2019 - SHIRLEY, NY, UNITED STATES – Jun 24, 2019 - CD Genomics, the USA-based genetic sequencing company and an expert in transcriptomics and next generation sequencing, announces the technical escalation of sequencing services, The updated service ranges include five: mitochondrial DNA sequencing, microbial whole genome sequencing, plasmid DNA sequencing, SMRT sequencing and bacterial genome sequencing, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivity
    Full story
  • Steven Daniel joins Cofactor Genomics as Vice President of Business Development

    Jun 20, 2019, 15:00 PM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - Jun 20, 2019 - Cofactor Genomics today announced the appointment of Steven Daniel, PhD as Vice President of Business Development, overseeing the development and execution of the company’s sales strategy and sales management
    Full story
  • International Women in Engineering Day 2019: Watson-Marlow Fluid Technology Group partners with Goonhilly Earth Station to inspire next generation of female engineers

    Jun 20, 2019, 06:44 AM by Michael Croft
    FALMOUTH, UK - Jun 20, 2019 - One of the South West’s biggest technology companies, Falmouth-based Watson-Marlow Fluid Technology Group (WMFTG) – part of Spirax-Sarco Engineering plc – will celebrate International Women in Engineering Day (INWED) in partnership with Goonhilly Earth Station
    Full story
  • Scilligence and TetraScience Announce Integration Plan to Automate Research Data

    Jun 19, 2019, 20:01 PM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Jun 19, 2019 - Scilligence and TetraScience announce a new integration between their products to automate data management across R&D workflows
    Full story
  • IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity

    Jun 19, 2019, 14:28 PM by Michael Croft
    NEW YORK, NY, UNITED STATES - Jun 13, 2019 - IBM (NYSE:IBM), KPMG, Merck (NYSE:MRK), and Walmart (NYSE: WMT) today announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a program in support of the U
    Full story
  • Shimmer and ClearSky Announce Partnership to Improve Analysis of Wearable Sensor Data for CNS Diseases

    Jun 19, 2019, 08:17 AM by Michael Croft
    CAMBRIDGE, MA - Jun 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research
    Full story
  • IDBS E-WorkBook chosen by Solvay for global R&I digital transformation

    Jun 19, 2019, 05:43 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Jun 19, 2019 - IDBS' E-WorkBook has been implemented by Solvay, an advanced materials and specialty chemicals company, as part of a digital transformation project that has removed paper-based processes across the organization
    Full story
  • Aircuity Announces Project with Net Zero Wilde Lake Middle School

    Jun 18, 2019, 11:02 AM by Michael Croft
    , N/A - Jun 18, 2019 -  NEWTON, Mass., USA - Aircuity (www.aircuity.com), creator of measurably better environments, announced the installation of its platform at Wilde Lake Middle School in Howard County, Maryland
    Full story
  • Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities

    Jun 18, 2019, 09:52 AM by Michael Croft
    WAYNE, PA - Jun 18, 2019 - Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health, today announced  its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to enhance overall data quality oversight and ensure regulatory compliance within clinical trials
    Full story
  • High-Confidence Characterization Of Small Molecule 'Unknowns': How Software Is Enabling Intelligent, High-Resolution Accurate Mass LC-MS/MS Data Acquisition

    Jun 17, 2019, 07:35 AM by Michael Croft

    Bio-IT World Contributed Commentary | Liquid chromatography-tandem mass spectrometry has proven to be a powerful tool for small molecule analysis. However, the identification of so-called "unknown-unknowns" is extremely challenging.

    Full story
  • Deep Genomics Identifies Rare Disease Targets Using AI System

    Jun 14, 2019, 13:25 PM by Michael Croft

    Bio-IT World News Brief | Deep Genomics' AI system has identified 1,600 rare disease targets that can be drugged using its splice-switching oligonucleotide technology.

    Full story
  • Rho Facilitates Conversation on Change and Collaboration at DIA 2019

    Jun 13, 2019, 19:41 PM by Michael Croft
    DURHAM, NC - Jun 14, 2019 - Rho Facilitates Conversation on Change and Collaboration at DIA 2019Experts fromCRO to share best practices and lessons learned on Change Management andEffective Stakeholder Collaboration   WHAT:                 Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the Drug Information Association (DIA) Annual Meeting, being held June 23-27 in San Francisco
    Full story
  • «
  • 241
  • 242
  • 243 (current)
  • 244
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy